Mini Review
Crohn’s Disease: A Curable Disease Held Hostage?
Infectious Diseases Incorporated, University of Bellevue USA
Received Date: May 15, 2021; Published Date: May 28, 2021
Introduction
Permanent remissions have been attained in Crohn’s disease. Nevertheless, the current focus of therapy remains sclerosed with the prevailing drug therapy through which temporary remissions are attainable. FDA’s reliance on evidence-based validation through comparative, placebo controlled, double-blinded studies has created an impediment to acceptance of divergent alternated therapies as being within the standard of care. In so doing, FDA has basically surrendered the therapeutic dialogue of Crohn’s disease to those who can pay for such studies.
Keywords: Crohn’s disease; Hruska Postulate; Permanent remission
Signup for Newsletter
